Načítá se...
First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma
BACKGROUND AND AIM: To investigate the efficacy of platinum-based chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma (mGEP-NEC) and define predictive and prognostic factors. METHODS: Twenty mGEP-NEC patients were treated with cisplatin or carboplatin/etoposide b...
Uloženo v:
Vydáno v: | Onco Targets Ther |
---|---|
Hlavní autoři: | , , , , , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Dove Medical Press
2015
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4671803/ https://ncbi.nlm.nih.gov/pubmed/26664145 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S91971 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|